TABLE 5.
Adverse events reported in ≥2% of patients in the ITT population
| Adverse event | No. (%) of patients in treatment group
|
|
|---|---|---|
| Linezolid (n = 400) | Oxacillin-dicloxacillin (n = 419) | |
| Nausea | 23 (5.8) | 24 (5.7) |
| Headache | 22 (5.5) | 16 (3.8) |
| Vomiting | 13 (3.3) | 8 (1.9) |
| Hypertension | 12 (3.0) | 1 (0.2) |
| Diarrhea | 11 (2.8) | 12 (2.9) |
| Localized pain | 11 (2.8) | 3 (0.7) |
| Dyspepsia | 10 (2.5) | 7 (1.7) |
| Insomnia | 10 (2.5) | 9 (2.1) |
| Dizziness | 9 (2.3) | 3 (0.7) |
| Abdominal pain (localized) | 8 (2.0) | 5 (1.2) |
| Constipation | 7 (1.8) | 13 (3.1) |
| Pruritus (nonapplication site) | 6 (1.5) | 9 (2.1) |
| Fever | 5 (1.3) | 11 (2.6) |